by admin | May 14, 2018 | Article
Application Metrics: 3/6 Applications Funded Principal Investigator: Dr. Zahi Touma Institution: Toronto Western Hospital – University Health Network; University of Toronto Project Title: RIPK3: Improving the assessment and...
by admin | Apr 19, 2018 | Article
Competition Catalyst Grant 2018-19 Application Metrics: 2/8 Applications Funded Principal Investigator: Dr. Joan Wither Institution: University Health Network Project Title: Using CyTOF to dissect the interplay between Type I...
by admin | May 13, 2016 | Article
Application Metrics: 2/6 Applications Funded Principal Investigator: Dr. Murray B. Urowitz Institution: University Health Network, Krembil Research Institute Project Title: Scrutinizing the Heterogeneity of Systemic Lupus...
by admin | May 13, 2016 | Article
Application Metrics: 2/6 Applications Funded Principal Investigator: Dr. William T. Gibson Institution: University of British Columbia Project Title: Role of Topoisomerase Genes in Childhood-Onset SLE Funding...
by admin | Jul 12, 2011 | Article
July 12, 2011 – Health Canada’s recent approval of BENLYSTA™ marks the first new treatment available in almost 50 years to the over 1:1000 Canadian men, women and children who are living with Systemic Lupus Erythematosus (SLE) an autoimmune disease with no known...
